THIOGUANINE Side Effects

6541192-8 | Abdominal Pain, Ascites, Hepatomegaly, Platelet Disorder
on Jan 13, 2010 Male patient from UNITED KINGDOM , child 11 years of age, weighting 79.15 lb, was treated with Thioguanine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), ascites, hepatomegaly, platelet disorder. Thioguanine dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DEXAMETHASONE (12mg Per Day) (View Dexamethasone Review and Dexamethasone Label ), SEPTRIN (960mg Per Day) (View Septrin Review and Septrin Label ), CYCLOPHOSPHAMIDE (1300mg Per Day) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6401541-8 | Abdominal Distension, Activated Partial Thromboplastin Time Prolonged, Alanine Aminotransferase Increased, Ammonia Increased, Anoxic Encephalopathy, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Brain Herniation
Patient was taking Thioguanine (View Usage). Patient had the following side effects: abdominal distension, activated partial thromboplastin time prolonged, alanine aminotransferase increased, ammonia increased, anoxic encephalopathy, aspartate aminotransferase increased, blood bilirubin increased, brain herniation on Oct 13, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 58.42 lb, . Thioguanine dosage: 800 Mg. During the same period patient was treated with VINCRISTINE SULFATE (4.2 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CYCLOPHOSPHAMIDE (950 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (560 Mg) (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE (133 Mg) (View Dexamethasone Review and Dexamethasone Label ), DOXORUBICIN HCL (72 Mg) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), METHOTREXATE (24 Mg) (View Methotrexate Review and Methotrexate Label ), ONCASPAR (2375 Mg) (View Oncaspar Review and Oncaspar Label ). Patient was hospitalized.

6140357-7 | Mucoepidermoid Carcinoma
Adverse event was reported on Mar 25, 2009 by a Male patient taking Thioguanine (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia and. Location: KOREA, REPUBLIC OF , child 5 years of age, After Thioguanine was administered, patient had the following side effects: mucoepidermoid carcinoma. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6132159-2 | Mass, Mucoepidermoid Carcinoma, Skin Lesion
on Mar 06, 2009 Male patient from KOREA, REPUBLIC OF , child 5 years of age, was treated with Thioguanine (View Usage). Patient experienced the following unwanted or unexpected effects: mass, mucoepidermoid carcinoma, skin lesion. Thioguanine dosage: . During the same period patient was treated with BUSULFAN (View Busulfan Review and Busulfan Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ETOPOSIDE (1600mgm2 Per Day) (View Etoposide Review and Etoposide Label ), CYCLOPHOSPHAMIDE (120mgk Per Day) (View Cyclophosphamide Review and Cyclophosphamide Label ).


6126200-0 | Mass, Mucoepidermoid Carcinoma, Skin Lesion
on Mar 06, 2009 Male patient from KOREA, REPUBLIC OF , child 5 years of age, was treated with Thioguanine (View Usage). Patient had the following side effects: mass, mucoepidermoid carcinoma, skin lesion. Thioguanine dosage: . During the same period patient was treated with BUSULFAN (View Busulfan Review and Busulfan Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN (View Daunorubicin Review and Daunorubicin Label ), ETOPOSIDE (1600mgm2 Per Day) (View Etoposide Review and Etoposide Label ), CYCLOPHOSPHAMIDE (120mgk Per Day) (View Cyclophosphamide Review and Cyclophosphamide Label ).

6123835-6 | Abdominal Distension, Alanine Aminotransferase Increased, Ammonia Increased, Anxiety, Ascites, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Amylase Decreased, Blood Bilirubin Increased
Patient was taking Thioguanine (View Usage). After Thioguanine was administered, patient had the following side effects: abdominal distension, alanine aminotransferase increased, ammonia increased, anxiety (What is anxiety?), ascites, aspartate aminotransferase increased, blood albumin decreased, blood amylase decreased, blood bilirubin increased on Mar 17, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 50.71 lb, . Thioguanine dosage: 720 Mg. Patient was hospitalized.

6109273-0 | Cholestasis, Pancytopenia, Portal Hypertension, Refusal Of Treatment By Patient
Adverse event was reported on Feb 19, 2009 by a Female patient taking Thioguanine (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED KINGDOM , 57 years of age, Patient experienced the following unwanted or unexpected effects: cholestasis, pancytopenia, portal hypertension, refusal of treatment by patient.

6088188-0 | Alanine Aminotransferase Increased, Ammonia Increased, Anxiety, Ascites, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Amylase Decreased, Blood Bilirubin Increased, Blood Lactic Acid Decreased
on Feb 18, 2009 Male patient from UNITED STATES , weighting 50.71 lb, was treated with Thioguanine (View Usage). Patient had the following side effects: alanine aminotransferase increased, ammonia increased, anxiety (What is anxiety?), ascites, aspartate aminotransferase increased, blood albumin decreased, blood amylase decreased, blood bilirubin increased, blood lactic acid decreased. Thioguanine dosage: 720 Mg. Patient was hospitalized.

6075158-1 | Abdominal Distension, Alanine Aminotransferase Increased, Ammonia Increased, Anxiety, Ascites, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Amylase Abnormal, Blood Bilirubin Increased
on Feb 10, 2009 Male patient from UNITED STATES , weighting 50.71 lb, was treated with Thioguanine (View Usage). After Thioguanine was administered, patient had the following side effects: abdominal distension, alanine aminotransferase increased, ammonia increased, anxiety (What is anxiety?), ascites, aspartate aminotransferase increased, blood albumin decreased, blood amylase abnormal, blood bilirubin increased. Thioguanine dosage: 720 Mg. Patient was hospitalized.

5897630-7 | Anaemia, Ascites, Biopsy Liver Abnormal, Colitis Ulcerative, Gamma-glutamyltransferase Increased, Haematemesis, Hepatic Enzyme Increased, Hepatic Fibrosis
Patient was taking Thioguanine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, ascites, biopsy liver abnormal, colitis ulcerative, gamma-glutamyltransferase increased, haematemesis, hepatic enzyme increased, hepatic fibrosis on Sep 09, 2008 from AUSTRIA Additional patient health information: Female patient , 56 years of age, was diagnosed with inflammatory bowel disease and. Thioguanine dosage: 40 Mg Per Day. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5844904-1 | Abdominal Distension, Eating Disorder, Liver Injury, Osteonecrosis, Renal Injury
Adverse event was reported on Aug 13, 2008 by a Male patient taking Thioguanine (View Usage) (Dosage: 60 Mg Daily Po) was diagnosed with leukaemia and. Location: UNITED STATES , child 7 years of age, weighting 64.00 lb, Patient had the following side effects: abdominal distension, eating disorder (What is eating disorder?), liver injury, osteonecrosis (What is osteonecrosis?), renal injury. Patient was hospitalized.

5768243-2 | Anaemia, Ascites, Colitis Ulcerative, Haematemesis, Hypoalbuminaemia, Leukopenia, Malnutrition, Oedema Peripheral
on May 28, 2008 Female patient from AUSTRIA , 56 years of age, was diagnosed with inflammatory bowel disease and was treated with Thioguanine (View Usage). After Thioguanine was administered, patient had the following side effects: anaemia, ascites, colitis ulcerative, haematemesis, hypoalbuminaemia, leukopenia, malnutrition, oedema peripheral. Thioguanine dosage: 40mg / Per Day. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5100631-X | Acute Myeloid Leukaemia Recurrent, Staphylococcal Sepsis, Transplant Failure
on Aug 23, 2006 Male patient from GERMANY , 48 years of age, was diagnosed with acute myeloid leukaemia and was treated with Thioguanine (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia recurrent, staphylococcal sepsis, transplant failure. Thioguanine dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

5081309-8 | Abdominal Distension, Abdominal Pain, Ascites, Burning Sensation, Contusion, Crying, Dysuria, Fatigue, Hepatomegaly
Patient was taking Thioguanine (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), ascites, burning sensation, contusion, crying, dysuria, fatigue, hepatomegaly on Aug 14, 2006 from UNITED STATES Additional patient health information: Male patient , child 3. years of age, weighting 42.99 lb, was diagnosed with acute lymphocytic leukaemia and. Thioguanine dosage: 40 Mg 1 Tab X 14 Days Po. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), ARAC (View Arac Review and Arac Label ).

5050851-8 | Clubbing, Hepatosplenomegaly, Hepatotoxicity, Platelet Count Decreased, Telangiectasia
Adverse event was reported on Jun 28, 2006 by a Male patient taking Thioguanine (View Usage) (Dosage: ) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED KINGDOM , child 6 years of age, After Thioguanine was administered, patient had the following side effects: clubbing, hepatosplenomegaly, hepatotoxicity, platelet count decreased, telangiectasia.

5050850-6 | Gastric Varices, Hepatosplenomegaly, Hepatotoxicity, Oesophageal Varices Haemorrhage, Platelet Count Decreased, Ultrasound Scan Abnormal
on Jun 28, 2006 Female patient from UNITED KINGDOM , child 12 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Thioguanine (View Usage). Patient experienced the following unwanted or unexpected effects: gastric varices, hepatosplenomegaly, hepatotoxicity, oesophageal varices haemorrhage, platelet count decreased, ultrasound scan abnormal. Thioguanine dosage: .

5050849-X | Duodenal Varices, Gastric Varices, Gastrointestinal Haemorrhage, Hepatosplenomegaly, Hepatotoxicity, Platelet Count Decreased
on Jun 28, 2006 Male patient from UNITED KINGDOM , child 11 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Thioguanine (View Usage). Patient had the following side effects: duodenal varices, gastric varices, gastrointestinal haemorrhage, hepatosplenomegaly, hepatotoxicity, platelet count decreased. Thioguanine dosage: .

5050848-8 | Gastric Varices, Gastrointestinal Haemorrhage, Hepatotoxicity, Platelet Count Decreased, Splenomegaly, Varices Oesophageal
Patient was taking Thioguanine (View Usage). After Thioguanine was administered, patient had the following side effects: gastric varices, gastrointestinal haemorrhage, hepatotoxicity, platelet count decreased, splenomegaly, varices oesophageal on Jun 28, 2006 from UNITED KINGDOM Additional patient health information: Male patient , child 12 years of age, was diagnosed with acute lymphocytic leukaemia and. Thioguanine dosage: .

4924628-5 | Anorexia, Asthenia, Hidradenitis, Malaise, Pyrexia, Skin Lesion
Adverse event was reported on Feb 08, 2006 by a Male patient taking Thioguanine (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia and. Location: SPAIN , 70 years of age, Patient experienced the following unwanted or unexpected effects: anorexia, asthenia, hidradenitis (What is hidradenitis?), malaise, pyrexia, skin lesion. Patient was hospitalized.

4919871-5 | Blood Bilirubin Increased, Haemoglobin Decreased, Hepatomegaly, Platelet Count Decreased, Venoocclusive Disease, Vomiting, White Blood Cell Count Decreased
on Feb 21, 2006 Female patient from UNITED STATES , weighting 25.13 lb, was diagnosed with b precursor type acute leukaemia and was treated with Thioguanine (View Usage). Patient had the following side effects: blood bilirubin increased, haemoglobin decreased, hepatomegaly, platelet count decreased, venoocclusive disease, vomiting, white blood cell count decreased. Thioguanine dosage: 560 Mg. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

4898004-8 | Abdominal Pain, Focal Nodular Hyperplasia, Hepatotoxicity, Obliterative Bronchiolitis, Weight Decreased
on Jan 19, 2006 Male patient from UNITED STATES , child 6 years of age, was diagnosed with acute myeloid leukaemia and was treated with Thioguanine (View Usage). After Thioguanine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), focal nodular hyperplasia, hepatotoxicity, obliterative bronchiolitis, weight decreased. Thioguanine dosage: . During the same period patient was treated with MYLERAN (View Myleran Review and Myleran Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), HEMATOPOETIC PROGENITOR CELLS HUMAN (View Hematopoetic Progenitor Cells Human Review and Hematopoetic Progenitor Cells Human Label ).

4845339-0 | Abdominal Distension, Abdominal Pain Upper, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cholestasis, Colitis Ulcerative, Diarrhoea, Gamma-glutamyltransferase Increased, Haematochezia
Patient was taking Thioguanine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain upper, blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, colitis ulcerative, diarrhoea, gamma-glutamyltransferase increased, haematochezia on Nov 28, 2005 from AUSTRIA Additional patient health information: Female patient , 69 years of age, . Thioguanine dosage: . Patient was hospitalized.

4844212-1 | Portal Vein Thrombosis
Adverse event was reported on Nov 30, 2005 by a Male patient taking Thioguanine (View Usage) (Dosage: 80mg Two Times Per Week) was diagnosed with psoriasis and. Location: UNITED STATES , 67 years of age, Patient had the following side effects: portal vein thrombosis. Patient was hospitalized.

4844211-X | Deep Vein Thrombosis, Pulmonary Embolism
on Nov 30, 2005 Female patient from UNITED STATES , 43 years of age, was diagnosed with psoriasis and was treated with Thioguanine (View Usage). After Thioguanine was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Thioguanine dosage: 240mg Two Times Per Week. During the same period patient was treated with BIRTH CONTROL (View Birth Control Review and Birth Control Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

4795335-7 | Asthenia, Diarrhoea, Folliculitis, Glossitis, Leukopenia, Pain In Extremity, Platelet Count Increased, Pyrexia, Rash Papular
on Jul 28, 2005 Male patient from GERMANY , 67 years of age, weighting 158.7 lb, was diagnosed with acute myeloid leukaemia, pain (What is pain?) and was treated with Thioguanine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, diarrhoea, folliculitis, glossitis, leukopenia, pain in extremity, platelet count increased, pyrexia, rash papular. Thioguanine dosage: . During the same period patient was treated with ALEXAN (View Alexan Review and Alexan Label ), DAUNOBLASTIN (110mg Per Day) (View Daunoblastin Review and Daunoblastin Label ), NOVANTRONE (18mg Per Day) (View Novantrone Review and Novantrone Label ), OXYGESIC (30mg Per Day) (View Oxygesic Review and Oxygesic Label ). Patient was hospitalized.

4789826-2 | Asthenia, Folliculitis, Glossitis, Leukopenia, Pain In Extremity, Pyrexia, Rash Papular, Thrombocytopenia, Visual Disturbance
Patient was taking Thioguanine (View Usage). Patient had the following side effects: asthenia, folliculitis, glossitis, leukopenia, pain in extremity, pyrexia, rash papular, thrombocytopenia, visual disturbance on Jul 28, 2005 from GERMANY Additional patient health information: Male patient , 66 years of age, weighting 158.7 lb, was diagnosed with pain (What is pain?) and. Thioguanine dosage: . During the same period patient was treated with ALEXAN (View Alexan Review and Alexan Label ), DAUNOBLASTIN (110mg Per Day) (View Daunoblastin Review and Daunoblastin Label ), NOVANTRONE (18mg Per Day) (View Novantrone Review and Novantrone Label ), OXYGESIC (30mg Per Day) (View Oxygesic Review and Oxygesic Label ).

4735654-3 | Folliculitis, Glossitis, Leukopenia, Pyrexia, Rash Papular, Thrombocytopenia, Visual Disturbance, Vomiting
Adverse event was reported on Jul 28, 2005 by a Male patient taking Thioguanine (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia, pain (What is pain?) and. Location: GERMANY , 66 years of age, weighting 158.7 lb, After Thioguanine was administered, patient had the following side effects: folliculitis, glossitis, leukopenia, pyrexia, rash papular, thrombocytopenia, visual disturbance, vomiting. During the same period patient was treated with ALEXAN (380mg Per Day) (View Alexan Review and Alexan Label ), DAUNOBLASTIN (110mg Per Day) (View Daunoblastin Review and Daunoblastin Label ), NOVANTRONE (View Novantrone Review and Novantrone Label ), OXYGESIC (30mg Per Day) (View Oxygesic Review and Oxygesic Label ).

4712233-5 | Blister, Chills, Decreased Activity, Dermatitis, Gastrointestinal Haemorrhage, Hypoxia, Mouth Ulceration, Mucosal Inflammation, Neutropenia
on Jun 02, 2005 Female patient from UNITED STATES , 15 years of age, weighting 156.5 lb, was treated with Thioguanine (View Usage). Patient experienced the following unwanted or unexpected effects: blister, chills, decreased activity, dermatitis, gastrointestinal haemorrhage, hypoxia, mouth ulceration, mucosal inflammation, neutropenia. Thioguanine dosage: 100mg Per Day. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAPSONE (View Dapsone Review and Dapsone Label ), ZOFRAN (View Zofran Review and Zofran Label ), ZANTAC (View Zantac Review and Zantac Label ), DEPO PROVERA (View Depo-provera Review and Depo-provera Label ). Patient was hospitalized.

4710833-X | Anaemia, Blister, Bursitis, Chills, Febrile Neutropenia, Hypotension, Lung Consolidation, Mucosal Inflammation, Nervous System Disorder
on Jun 02, 2005 Male patient from UNITED STATES , 16 years of age, weighting 181.4 lb, was treated with Thioguanine (View Usage). Patient had the following side effects: anaemia, blister, bursitis (What is bursitis?), chills, febrile neutropenia, hypotension, lung consolidation, mucosal inflammation, nervous system disorder. Thioguanine dosage: 100mg Per Day. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), STRATTERA (View Strattera Review and Strattera Label ), ZOFRAN (View Zofran Review and Zofran Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VISTARIL (View Vistaril Review and Vistaril Label ), ZANTAC (View Zantac Review and Zantac Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4688816-8 | Blister, Mucosal Inflammation, Pain, Pancytopenia, Rash Erythematous, Skin Exfoliation
Patient was taking Thioguanine (View Usage). After Thioguanine was administered, patient had the following side effects: blister, mucosal inflammation, pain (What is pain?), pancytopenia, rash erythematous, skin exfoliation on Jun 02, 2005 from Additional patient health information: Male patient , 16 years of age, . Thioguanine dosage: 100mg Per Day. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), STRATTERA (View Strattera Review and Strattera Label ), ZOFRAN (View Zofran Review and Zofran Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VISTARIL (View Vistaril Review and Vistaril Label ), ZANTAC (View Zantac Review and Zantac Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4688803-X | Blister, Gastrointestinal Haemorrhage, Mucosal Inflammation, Pain, Pancytopenia, Rash Erythematous, Skin Exfoliation
Adverse event was reported on Jun 02, 2005 by a Female patient taking Thioguanine (View Usage) (Dosage: 100mg Per Day) was diagnosed with acute lymphocytic leukaemia and. Location: , 14 years of age, Patient experienced the following unwanted or unexpected effects: blister, gastrointestinal haemorrhage, mucosal inflammation, pain (What is pain?), pancytopenia, rash erythematous, skin exfoliation. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAPSONE (View Dapsone Review and Dapsone Label ), ZOFRAN (View Zofran Review and Zofran Label ), ZANTAC (View Zantac Review and Zantac Label ), DEPO PROVERA (View Depo-provera Review and Depo-provera Label ). Patient was hospitalized.